Related Experiment Video
Updated: Jun 4, 2026

07:17
Single Port Donor Nephrectomy
Published on: March 12, 2011
Prospective, nonrandomized comparison between right- and left-sided hand-assisted laparoscopic donor nephrectomy.
1Clinic for Urology and Kidney Transplantation Center, University Medical School of Martin-Luther-University Halle/Wittenberg, Halle, Germany. rhoda@ucsd.edu
Transplantation Proceedings
|February 22, 2011
Summary
Right-sided, hand-assisted, laparoscopic donor nephrectomy (HALDN) provides adequate right renal vessel length, proving as safe and feasible as the left-sided approach. This technique ensures comparable graft survival and donor outcomes.
Area of Science:
- Urology
- Transplant Surgery
- Minimally Invasive Surgery
Background:
- Laparoscopic living donor right nephrectomy presents challenges in achieving sufficient right renal vessel length.
- Hand-assistance is explored to overcome these technical limitations.
Purpose of the Study:
- To evaluate the safety and feasibility of right-sided, hand-assisted, laparoscopic donor nephrectomy (HALDN).
- To compare perioperative outcomes and graft survival between right and left HALDN.
Main Methods:
- A 7-year prospective study (2003-2010) involving 51 right HALDN and 40 left HALDN procedures.
- Perioperative data collection included procedure time, blood loss, warm ischemia time, and complications.
- One-year graft survival was calculated using the Kaplan-Meier method.
Main Results:
- No conversions to open surgery were required for either group.
- Mean procedure time (123 min vs. 135 min) and blood loss (92 mL vs. 101 mL) were similar between right and left HALDN.
- No instances of renal artery or vein thrombosis were observed; 1-year graft survival was high and comparable (98.1% vs. 97.5%).
Conclusions:
- Right HALDN is a safe and feasible alternative to left HALDN.
- Hand-assistance effectively provides adequate right renal vessel length without increasing vascular complications.
- The technique demonstrates excellent donor and recipient outcomes, including high graft survival rates.

